Top Markets
Coin of the day
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
Pozycja w akcjach #18285
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
Cena akcji
$5.59
Ostatnia synchronizacja: 2026-09-02
Kapitalizacja rynkowa
$205.21M
Zmiana (1 dzień)
6.27%
Zmiana (1 rok)
86.33%
Kraj
US
Handel Armata Pharmaceuticals, Inc. (ARMP)

Kategoria

Historia stopy dywidendy dla Armata Pharmaceuticals, Inc. (ARMP)
Stopa dywidendy (TTM) dla Armata Pharmaceuticals, Inc. (symbol akcji: ARMP) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Armata Pharmaceuticals, Inc. (ARMP) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji